Get startedLog in
    Picture of Gensight Biologics SA logo

    SIGHT — Gensight Biologics SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Gensight Biologics Announces Successful Completion Of Lumevoq® Engineering Batch Validating Implemented Corrective Actions

    Picture of Gensight Biologics SA logoGensight Biologics SA
    19/09/2022 06:36
    Sept 19 (Reuters) - Gensight Biologics SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS ANNOUNCES SUCCESSFUL COMPLETION OF
LUMEVOQ®
ENGINEERING BATCH VALIDATING IMPLEMENTED CORRECTIVE ACTIONS
    * COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
OPINION
STILL EXPECTED BY Q3 2023

Source text for Eikon:  ID:nBw3l972Sa 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Gensight Biologics SA

    See all news